Rising Prevalence Of Gastrointestinal Disorders Fueling The Growth Of The Market Due To Changing Lifestyle Patterns: A Key Catalyst Accelerating Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market Growth in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Remote Irritable Bowel Syndrome (IBS) Monitoring Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The global market for remote monitoring of irritable bowel syndrome (IBS) has experienced swift escalation lately, projected to advance from its 2024 valuation of $1.21 billion to $1.40 billion in 2025, reflecting a strong compound annual growth rate of 16.2%. This upward trajectory during the past period stems from several interconnected factors: the heightened incidence of gastrointestinal ailments, elevated public knowledge concerning IBS and overall digestive wellness, a greater need for methods of observation that do not require invasive procedures, the wider acceptance of digital health technologies, increased usage of mobile devices and wearables, climbing spending on medical services, and a stronger emphasis on care tailored to the individual patient.

Remote Irritable Bowel Syndrome (IBS) Monitoring Market Size Forecast: What's the Projected Valuation by 2029?
Anticipation surrounds the remote irritable bowel syndrome (IBS) monitoring sector, which is projected for swift expansion in the approaching years, achieving a valuation of $2.53 billion by 2029, propelled by a compound annual growth rate (CAGR) of 15.8percent. This forward momentum in the projection timeframe stems from several factors: the escalating adoption of networked hardware for gastrointestinal oversight, deeper embedding of remote monitoring within telehealth frameworks and virtual consultations, increasing preference for bespoke therapeutic regimens, and the broader deployment of distant patient supervision initiatives. During this forecast span, key directional shifts will feature technological progress within biosensors and wearable gadgets, novelties in symptom logging powered by artificial intelligence, maturation of cloud-hosted health infrastructures, ongoing investigative work into gut microbiome assessment, incorporation of digital therapies alongside mobile applications, and the utilization of data analysis techniques for forecasting and immediate status tracking.

View the full report here:
https://www.thebusinessresearchcompany.com/report/remote-irritable-bowel-syndrome-ibs-monitoring-global-market-report

What Are the Drivers Transforming the Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
The anticipated rise in the incidence of digestive system ailments is set to fuel the expansion of the remote irritable bowel syndrome (IBS) surveillance sector in the near future. Digestive tract conditions, which disrupt the standard operation of the alimentary canal, interfering with both nutrient absorption and intestinal control, are becoming more common. This escalation in gastrointestinal issues primarily stems from detrimental eating patterns that negatively impact intestinal wellness and digestion, thus inducing inflammatory responses and digestive discomfort such as excessive fullness and unease. Through enabling prompt recognition of causal factors and continuous oversight, remote IBS monitoring contributes to lessening symptom intensity and decelerating the advancement of the illness, resulting in enhanced patient recovery and a superior standard of living. As an illustration, data from Crohn's & Colitis Australia, a representative body in that nation, indicated in February 2025 that the estimated number of inflammatory bowel disease (IBD) instances across Australia is projected to climb from 20,511,881 in 2023 to reach 23,067,771 by the year 2030. Consequently, the expanding frequency of gastrointestinal disorders serves as a primary impetus for the growth trajectory of the remote irritable bowel syndrome market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29175&type=smp

What Long-Term Trends Will Define the Future of the Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
Key players within the remote irritable bowel syndrome (IBS) observation sector are prioritizing the creation of either white-label or co-branded service arrangements, aiming to capitalize on existing robust digital infrastructures and established clinical support frameworks. These service structures-white-label or co-branded-empower healthcare facilities to roll out pre-built digital wellness solutions directly under their own branding, thus marrying their familiar reputation with validated technology for quicker implementation, reduced expenditures, and an uninterrupted patient journey. As a concrete illustration, in May of 2024, Salvo Health, an American firm specializing in digital gastrointestinal care, unveiled its inaugural remote patient monitoring (RPM) facilitation system tailored for persistent GI ailments. This initiative introduces a fresh digital care pathway for issues like IBS, GERD, dyspepsia, celiac disease, and SIBO, permitting gastroenterology practices to integrate remote tracking methods alongside conventional face-to-face treatment. Salvo facilitates this by supplying local GI practitioners with requisite digital instruments, specialized clinical personnel, and at-home monitoring hardware via its white-label or co-branded methodology, enabling the tracking of heart rate variability (HRV) and correlating this data with patient dietary habits, conduct, and reported symptoms to enhance the results of chronic care management and overall practice productivity.

Which Segments in the Remote Irritable Bowel Syndrome (IBS) Monitoring Market Offer the Most Profit Potential?
The remote irritable bowel syndrome (ibs) monitoringmarket covered in this report is segmented -

1) By Component: Devices, Software, Services
2) By Application: Diagnosis, Symptom Tracking, Treatment Management, Patient Education, Other Applications
3) By End-User: Hospitals And Clinics, Homecare Settings, Research Institutes, Other End-Users

Subsegments:
1) By Devices: Wearable Monitoring Devices, Non-Wearable Monitoring Devices, Portable Monitoring Devices, Implantable Monitoring Devices
2) By Software: Data Analytics Software, Mobile Health Applications, Remote Monitoring Platforms, Cloud-Based Software Solutions
3) By Services: Teleconsultation Services, Data Management Services, Technical Support Services, Training And Education Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=29175&type=smp

Which Firms Dominate the Remote Irritable Bowel Syndrome (IBS) Monitoring Market by Market Share and Revenue in 2025?
Major companies operating in the remote irritable bowel syndrome (IBS) monitoring market are Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., Seed Health, Ayble Health, Oshi health, Salvo Health Inc., modifyhealth Inc., Food marble, nerva health, MyGiHealth, Sun Genomics, Dietahealth, Dige Health, Nori health, Sequenex, and Bowelle.

Which Regions Offer the Highest Growth Potential in the Remote Irritable Bowel Syndrome (IBS) Monitoring Market?
North America was the largest region in the remote irritable bowel syndrome (IBS) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote irritable bowel syndrome (IBS) monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=29175

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.